Envveno Medical Corp stock is traded at $5.25, with a volume of 10,355. It is down -5.75% in the last 24 hours and down -31.82% over the past month. enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Previous Close:
$5.57
Open:
$5.53
24h Volume:
10,355
Relative Volume:
1.01
Market Cap:
$3.65M
Revenue:
$186.70K
Net Income/Loss:
-$18.82M
P/E Ratio:
-
EPS:
-$31.19
Net Cash Flow:
-$14.79M
1W Performance:
-14.91%
1M Performance:
-31.82%
6M Performance:
-52.05%
1Y Performance:
-53.50%
1-Day Range:
$5.22$5.76
1-Week Range:
$5.22$6.50
52-Week Range:
$5.22$14.67
Envveno Medical Corp Stock (NVNO) Company Profile
Name
Envveno Medical CorpSector
HealthcareIndustry
Medical DevicesPhone
949-261-2900Address
70 DOPPLER, IRVINE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS